Trial intelligence / Profile preview

PHPT-5: Peripartum Nevirapine vs Lopinavir/Ritonavir for PMTCT

NCT00409591Phase 3Terminated

Sponsor
Institut de Recherche pour le Développement
Start
Jul 2008
Primary completion
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nevirapine, lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Institut de Recherche pour le Développement. Started Jul 2008; status: terminated.

02

Drugs

nevirapinelopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00409591.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00409591.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call